Bg Medicine Stock Working Capital
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
BG Medicine fundamentals help investors to digest information that contributes to BG Medicine's financial success or failures. It also enables traders to predict the movement of BGMD Pink Sheet. The fundamental analysis module provides a way to measure BG Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BG Medicine pink sheet.
BGMD |
BG Medicine Company Working Capital Analysis
BG Medicine's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current BG Medicine Working Capital | 771 K |
Most of BG Medicine's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, BG Medicine has a Working Capital of 771 K. This is 99.82% lower than that of the Life Sciences Tools & Services sector and 99.87% lower than that of the Health Care industry. The working capital for all United States stocks is 99.95% higher than that of the company.
BGMD Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BG Medicine's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BG Medicine could also be used in its relative valuation, which is a method of valuing BG Medicine by comparing valuation metrics of similar companies.BG Medicine is currently under evaluation in working capital category among its peers.
BGMD Fundamentals
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.86) % | ||||
| Current Valuation | 545.97 K | ||||
| Shares Outstanding | 11.37 M | ||||
| Number Of Shares Shorted | 630.05 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (4.39 M) | ||||
| Net Income | (5.3 M) | ||||
| Cash And Equivalents | 1.52 M | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 5.31 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (3.67 M) | ||||
| Short Ratio | 2.66 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 1.4 | ||||
| Beta | 83.44 | ||||
| Market Capitalization | 545.97 K | ||||
| Total Asset | 2.13 M | ||||
| Retained Earnings | (161.49 M) | ||||
| Working Capital | 771 K | ||||
| Current Asset | 1.95 M | ||||
| Current Liabilities | 1.18 M | ||||
| Net Asset | 2.13 M |
About BG Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BG Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BG Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BG Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |